4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride CAS 106261-49-8 Imatinib Mesylate Intermediate High Purity
Ubonelelo ngezoRhwebo i-Imatinib Mesylate kunye nabaPhakathi abaNxulumeneyo:
I-Imatinib Mesylate CAS: 220127-57-1
N-(2-Methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine CAS: 152460-09-8
N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidinea CAS: 152460-10-1
4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride CAS: 106261-49-8
Igama leMchiza | 4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride |
Izithethantonye | I-Imatinib Mesylate ePhakathi |
Inombolo yeCAS | 106261-49-8 |
Inombolo yeCAT | RF-PI229 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | I-C13H20Cl2N2O2 |
Ubunzima beMolekyuli | 307.22 |
Indawo yokunyibilika | 305.0~307.0℃ |
Ukunyibilika | Inyibilika emanzini |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Mhlophe ukuya Phantse uMhlophe uPowder ukuya kwiCrystal |
Ubunyulu / Indlela yokuHlalutya | ≥98.0% (HPLC) |
Ilahleko ekomisweni | ≤0.50% |
Intsalela ekutshisweni | ≤0.50% |
Ukungcola ngokupheleleyo | ≤2.0% |
Ukungacoceki okuphezulu okukodwa | ≤1.0% |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | I-Pharmaceutical Intermediate ye-Imatinib Mesylate (CAS: 220127-57-1) |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, igubu lekhadibhodi, 25kg/Igubu, okanye ngokwemfuno yomthengi.
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ekukhanyeni, ukufuma kunye nokuhlaselwa zizinambuzane.
I-Shanghai Ruifu Chemical Co., Ltd. ngumenzi ohamba phambili kunye nomthengisi we-4-[(4-Methylpiperazin-1-yl) methyl]benzoic acid dihydrochloride (CAS: 106261-49-8) enomgangatho ophezulu.Yonayindawo ephakathi ngokuqhelekileyo kwi-synthesis ye-Imatinib Mesylate (CAS: 220127-57-1).I-Imatinib Mesylate yi-tyrosine kinase inhibitor, ecacileyo kakhulu kwi-BCR-ABL, iyeza lomlomo lonyango lwezigulane zabantu abadala abane-Philadelphia chromosome positive chronic myeloid leukemia (CML) kwisigaba esinzima kunye neendlela ezithile ze-acute lymphoblastic leukemia (ALL), ikhawuleza. isigaba kunye nesigaba esingapheliyo emva kokungaphumeleli kwonyango lwe-interferon.